Cargando…
Ambroxol for the treatment of fibromyalgia: science or fiction?
Fibromyalgia appears to present in subgroups with regard to biological pain induction, with primarily inflammatory, neuropathic/neurodegenerative, sympathetic, oxidative, nitrosative, or muscular factors and/or central sensitization. Recent research has also discussed glial activation or interrupted...
Autores principales: | Kern, Kai-Uwe, Schwickert, Myriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566330/ https://www.ncbi.nlm.nih.gov/pubmed/28860846 http://dx.doi.org/10.2147/JPR.S139223 |
Ejemplares similares
-
Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?
por: Zaitoun, Mohamed M. A., et al.
Publicado: (2020) -
Fascial preadipocytes: another missing piece of the puzzle to understand fibromyalgia?
por: Bordoni, Bruno, et al.
Publicado: (2018) -
The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology
por: Hulens, Mieke, et al.
Publicado: (2018) -
An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue
por: Teitelbaum, Jacob, et al.
Publicado: (2021) -
Topical ambroxol for the treatment of neuropathic pain: An initial clinical observation. English version
por: Kern, K.-U., et al.
Publicado: (2015)